These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 7715091

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Diagnosis and treatment strategy for de novo AML with trilineage myelodysplasia].
    Kuriyama K.
    Rinsho Ketsueki; 1994 Mar; 35(3):267-71. PubMed ID: 8158847
    [Abstract] [Full Text] [Related]

  • 3. The significance of trilineage myelodysplasia in de novo acute myeloblastic leukemia: clinical and laboratory features.
    Lima CS, Vassalo J, Lorand-Metze I, Bechelli AP, Souza CA.
    Haematologia (Budap); 1997 Mar; 28(2):85-95. PubMed ID: 9283908
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Clinical significance of micromegakaryocytes in de novo AML].
    Kobayashi S, Seki K, Katayama N, Akiba C, Yamamoto T, Sakai K, Yamaguchi M, Maruta A, Noguchi T, Ogawa K.
    Rinsho Ketsueki; 1993 Mar; 34(3):313-20. PubMed ID: 8479083
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study.
    Wahlin A, Billström R, Björ O, Ahlgren T, Hedenus M, Höglund M, Lindmark A, Markevärn B, Nilsson B, Sallerfors B, Brune M.
    Eur J Haematol; 2009 Aug; 83(2):99-107. PubMed ID: 19385987
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Runde V, de Witte T, Arnold R, Gratwohl A, Hermans J, van Biezen A, Niederwieser D, Labopin M, Walter-Noel MP, Bacigalupo A, Jacobsen N, Ljungman P, Carreras E, Kolb HJ, Aul C, Apperley J.
    Bone Marrow Transplant; 1998 Feb; 21(3):255-61. PubMed ID: 9489648
    [Abstract] [Full Text] [Related]

  • 13. [Access to bone marrow transplantation in acute myeloblastic leukemia. Study of 52 patients treated in a single center].
    Tomás JF, Calvo JM, Gómez-García de Soria V, Pinilla I, Figuera A, Fernández-Rañada JM.
    Med Clin (Barc); 1997 May 31; 109(1):12-5. PubMed ID: 9303971
    [Abstract] [Full Text] [Related]

  • 14. Clinical and laboratory features of de novo acute myeloid leukaemia with trilineage myelodysplasia.
    Brito-Babapulle F, Catovsky D, Galton DA.
    Br J Haematol; 1987 Aug 31; 66(4):445-50. PubMed ID: 3478074
    [Abstract] [Full Text] [Related]

  • 15. Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia.
    Hofmann WK, Heil G, Zander C, Wiebe S, Ottmann OG, Bergmann L, Hoeffken K, Fischer JT, Knuth A, Kolbe K, Schmoll HJ, Langer W, Westerhausen M, Koelbel CB, Hoelzer D, Ganser A.
    Ann Hematol; 2004 Aug 31; 83(8):498-503. PubMed ID: 15156346
    [Abstract] [Full Text] [Related]

  • 16. Outcome assessment of age group-specific (+/- 50 years) post-remission consolidation with high-dose cytarabine or bone marrow autograft for adult acute myelogenous leukemia.
    Bassan R, Raimondi R, Lerede T, D'emilio A, Buelli M, Borleri G, Personeni A, Bellavita P, Rodeghiero F, Barbui T.
    Haematologica; 1998 Jul 31; 83(7):627-35. PubMed ID: 9718868
    [Abstract] [Full Text] [Related]

  • 17. Poor response to intensive chemotherapy in de novo acute myeloid leukaemia with trilineage myelodysplasia. Japan Adult Leukaemia Study Group (JALSG).
    Kuriyama K, Tomonaga M, Matsuo T, Kobayashi T, Miwa H, Shirakawa S, Tanimoto M, Adachi K, Emi N, Hiraoka A.
    Br J Haematol; 1994 Apr 31; 86(4):767-73. PubMed ID: 7918070
    [Abstract] [Full Text] [Related]

  • 18. Myelodysplastic relapse of de novo acute myeloid leukaemia with trilineage myelodysplasia: a previously unrecognized correlation.
    Brito-Babapulle F, Catovsky D, Galton DA.
    Br J Haematol; 1988 Apr 31; 68(4):411-5. PubMed ID: 3163932
    [Abstract] [Full Text] [Related]

  • 19. [Allogeneic bone marrow transplantation for two patients with acute myeloid leukemia with trilineage myelodysplasia (T-MDS)].
    Fukushima T, Kuriyama K, Yoshida S, Nagai K, Miyazaki Y, Moriuti Y, Tomonaga M.
    Rinsho Ketsueki; 1994 Feb 31; 35(2):171-6. PubMed ID: 8139116
    [Abstract] [Full Text] [Related]

  • 20. Unrelated bone marrow transplantation in patients with myelodysplastic syndromes and secondary acute myeloid leukemia: an EBMT survey. European Blood and Marrow Transplantation Group.
    Arnold R, de Witte T, van Biezen A, Hermans J, Jacobsen N, Runde V, Gratwohl A, Apperley JF.
    Bone Marrow Transplant; 1998 Jun 31; 21(12):1213-6. PubMed ID: 9674854
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.